The markets opened higher with the Dow climbing 74 points to 17,904 as crude oil prices rebounded. Nasdaq rose 13 points to 4,857.
On the upside
SkyPeople Fruit Juice (Nasdaq: SPU) subsidiary Hedetang Holdings entered a Share Transfer Agreement with Shaanxi New Silk Road Kiwifruit Group.
Inventergy Global (Nasdaq: INVT) received patent grants and notices of allowance for 23 patents in telecommunications and mobile broadband.
Nymox (Nasdaq: NYMX) reported positive results from a 7 year prospective placebo controlled double blind study of fexapotide to prevent prostate cancer.
On the downside
Tesla (Nasdaq: TSLA) offered a premium of approximately $2.8 billion to acquire SolarCity (Nasdaq: SCTY).
Emergent BioSolutions (NYSE: EBS) will respond to two solicitations issued by the Department of Health and Human Services to develop anthrax vaccines for the Strategic National Stockpile.
Inovio Pharmaceuticals (Nasdaq: INO) chief executive Joseph Kim said that it would take several years before a Zika vaccine would be available.
In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 gained 7 points to 2,096. Bitcoin climbed $11 to $657.
